Pemetrexed Injection, Powder, Lyophilized, For Solution
Product Images NDC 72603-425

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Pemetrexed (NDC 72603-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pem Hansoh Ns Fig1)

FDA Label Image

Figure 2 (Pem Hansoh Ns Fig2)

FDA Label Image

Figure 3 (Pem Hansoh Ns Fig3)

FDA Label Image

Figure 4 (Pem Hansoh Ns Fig4)

Not available.*

FDA Label Image

Figure 5 (Pem Hansoh Ns Fig5)

This is a data table showing survival probability and the number of patients at risk for each treatment group (pematesed and placebo). It also displays the survival time in months for the patients involved in the study.*

FDA Label Image

Figure 6 (Pem Hansoh Ns Fig6)

This is a table showing survival probability over time for patients treated with a drug (B i @ e 9 W g sar . a0 @y W%) compared to those who received a placebo. The table includes the number of patients at risk for each time point, starting from the initial cohort size and decreasing as time progresses. This data can be used to analyze the effectiveness of the drug in terms of survival rates over a certain period.*

FDA Label Image

Figure 7 (Pem Hansoh Ns Fig7)

This text provides data on survival probability and the number of patients at risk over time for two groups: pemeexed and Placebo. The survival time in months is also displayed. The group pemeexed has more patients at risk compared to the Placebo group at different time intervals.*

FDA Label Image

Figure 8 (Pem Hansoh Ns Fig8)

This is a table showing the survival probability and survival time in months for two groups of patients: Pemexsd and Placebo. The data includes the number of patients at risk for each timepoint.*

FDA Label Image

Figure 9 (Pem Hansoh Ns Fig9)

FDA Label Image

Structural Formula (Pem Hansoh Ns Struct)

FDA Label Image

Principal Display Panel – Pemetrexed For Injection, Usp Northstar 100 mg Carton (Peme Hansoh 100mg Ns Carton)

FDA Label Image

Principal Display Panel – Pemetrexed For Injection, Usp 100 mg Northstar Vial Label (Peme Hansoh 100mg Ns Cont)

FDA Label Image

Principal Display Panel – Pemetrexed For Injection, Usp Northstar 500 mg Carton (Peme Hansoh 500mg Ns Carton)

This text appears to be a pharmaceutical label for Pemetrexed for Injection USP, contained in a single-dose vial for intravenous use only. It provides information on the composition, reconstitution, dosage, administration, storage instructions, caution regarding its use as a cytotoxic agent, and manufacturing details including a contact address. It is essential for healthcare professionals to refer to this label for proper handling and administration of the medication.*

FDA Label Image

Principal Display Panel – Pemetrexed For Injection, Usp Northstar 500 mg Vial Label (Peme Hansoh 500mg Ns Cont)

This is a product description for "Pemetrexed for Injection", intended for intravenous use as a cytotoxic agent. The product is a single dose vial with NDC72603-425-01.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.